Page last updated: 2024-09-03

omega-n-methylarginine and Hypogonadism

omega-n-methylarginine has been researched along with Hypogonadism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardini, M; Bernini, G; Canale, D; Ghiadoni, L; Moretti, A; Salvetti, A; Taddei, S; Taurino, C; Versari, D; Virdis, A1
Dart, A; Esler, MD; Fullerton, M; Jennings, G; Komesaroff, PA; Sudhir, K1

Trials

1 trial(s) available for omega-n-methylarginine and Hypogonadism

ArticleYear
Low-dose estrogen supplementation improves vascular function in hypogonadal men.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:5

    Topics: Acetylcholine; Angiotensin II; Blood Pressure; Cardiotonic Agents; Cardiovascular Diseases; Double-Blind Method; Estrogens; Hemodynamics; Humans; Hypogonadism; Lipids; Male; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2001

Other Studies

1 other study(ies) available for omega-n-methylarginine and Hypogonadism

ArticleYear
Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:5

    Topics: Adult; Androgens; Arteries; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Hemodynamics; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Testosterone; Vascular Resistance; Vasodilator Agents

2006